Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

International Programs

  • Print
  • Share
  • E-mail
-

Middle East Office

Presentation in Pdf Format [108 KB]

Slide 1

FDA’s interactions with the Middle East are important because of:

  1. The sensitivity of products traded with the USA. The increased volume of trade in FDA-regulated products. 
  2. The need to learn more about the regulations of the region to make sure the products destined to US market are safe, effective, wholesome, and secure. 
  3. The increased production of generic drugs in the region. 
  4. The increased number of global drug companies conducting clinical testing in the region.

Slide 2: FY 2010 Goals

Our major objectives for the coming year will be:

  • Increase knowledge of counterpart regulatory authorities, USG entities, and international organizations with presence in MENA – continue information collection; 
  • Continue to triage inquiries from the ME countries; 
  • Assist in building regulatory and technical capacity at request of counterpart agencies – conduct a food safety workshop in the Middle east; and 
  • Coordinate and collaborate with USG in-country counterparts with complementary missions and with international organizations with activities in the Middle East.

 

-
-